Oral adverse events following COVID-19 and influenza vaccination in Australia

Vaccine hesitancy, spurred by misinterpretation of Adverse Events (AEs), threatens public health. Despite sporadic reports of oral AEs post-COVID-19 vaccination, systematic analysis is scarce. This study evaluates these AEs using the Australian Database of Adverse Event Notifications (DAEN). A secon...

Full description

Bibliographic Details
Main Authors: Abanoub Riad, Julien Issa, Sameh Attia, Ladislav Dušek, Miloslav Klugar
Format: Article
Language:English
Published: Taylor & Francis Group 2023-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2023.2253589
_version_ 1797633750126821376
author Abanoub Riad
Julien Issa
Sameh Attia
Ladislav Dušek
Miloslav Klugar
author_facet Abanoub Riad
Julien Issa
Sameh Attia
Ladislav Dušek
Miloslav Klugar
author_sort Abanoub Riad
collection DOAJ
description Vaccine hesitancy, spurred by misinterpretation of Adverse Events (AEs), threatens public health. Despite sporadic reports of oral AEs post-COVID-19 vaccination, systematic analysis is scarce. This study evaluates these AEs using the Australian Database of Adverse Event Notifications (DAEN). A secondary analysis of DAEN data was conducted, with the analysis period commencing from the start of the COVID-19 vaccination rollout in February 2021 and the inception of the influenza vaccine database in 1971, both through until December 2022. The focus of the analysis was on oral AEs related to COVID-19 and influenza vaccines. Reports were extracted according to a predefined schema and then stratified by vaccine type, sex, and age. Oral paresthesia was the most common oral AE after COVID-19 vaccination (75.28 per 10,000 reports), followed by dysgeusia (73.96), swollen tongue (51.55), lip swelling (49.43), taste disorder (27.32), ageusia (25.85), dry mouth (24.75), mouth ulceration (18.97), oral hypoaesthesia (15.60), and oral herpes (12.74). While COVID-19 and influenza vaccines shared most oral AEs, taste-related AEs, dry mouth, and oral herpes were significantly more common after COVID-19 vaccination. mRNA vaccines yielded more oral AEs than other types. Females had higher oral AE incidence. Most oral AEs did not differ significantly between COVID-19 and influenza vaccination. However, specific oral AEs, particularly taste-related, dry mouth, and oral herpes, were more prevalent after COVID-19 vaccination compared with seasonal influenza, especially in females and mRNA vaccine recipients.
first_indexed 2024-03-11T11:58:14Z
format Article
id doaj.art-e1ed41467a8e42df9342e2d7fe00359b
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T11:58:14Z
publishDate 2023-08-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-e1ed41467a8e42df9342e2d7fe00359b2023-11-08T11:55:20ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-08-0119210.1080/21645515.2023.22535892253589Oral adverse events following COVID-19 and influenza vaccination in AustraliaAbanoub Riad0Julien Issa1Sameh Attia2Ladislav Dušek3Miloslav Klugar4Institute of Health Information and Statistics of the Czech Republic (IHIS-CR)University of Medical SciencesJustus-Liebig-UniversityInstitute of Health Information and Statistics of the Czech Republic (IHIS-CR)Institute of Health Information and Statistics of the Czech Republic (IHIS-CR)Vaccine hesitancy, spurred by misinterpretation of Adverse Events (AEs), threatens public health. Despite sporadic reports of oral AEs post-COVID-19 vaccination, systematic analysis is scarce. This study evaluates these AEs using the Australian Database of Adverse Event Notifications (DAEN). A secondary analysis of DAEN data was conducted, with the analysis period commencing from the start of the COVID-19 vaccination rollout in February 2021 and the inception of the influenza vaccine database in 1971, both through until December 2022. The focus of the analysis was on oral AEs related to COVID-19 and influenza vaccines. Reports were extracted according to a predefined schema and then stratified by vaccine type, sex, and age. Oral paresthesia was the most common oral AE after COVID-19 vaccination (75.28 per 10,000 reports), followed by dysgeusia (73.96), swollen tongue (51.55), lip swelling (49.43), taste disorder (27.32), ageusia (25.85), dry mouth (24.75), mouth ulceration (18.97), oral hypoaesthesia (15.60), and oral herpes (12.74). While COVID-19 and influenza vaccines shared most oral AEs, taste-related AEs, dry mouth, and oral herpes were significantly more common after COVID-19 vaccination. mRNA vaccines yielded more oral AEs than other types. Females had higher oral AE incidence. Most oral AEs did not differ significantly between COVID-19 and influenza vaccination. However, specific oral AEs, particularly taste-related, dry mouth, and oral herpes, were more prevalent after COVID-19 vaccination compared with seasonal influenza, especially in females and mRNA vaccine recipients.http://dx.doi.org/10.1080/21645515.2023.2253589covid-19 vaccinesdrug-related side effects and adverse reactionsherpes zosterpharmacovigilancetaste disorders
spellingShingle Abanoub Riad
Julien Issa
Sameh Attia
Ladislav Dušek
Miloslav Klugar
Oral adverse events following COVID-19 and influenza vaccination in Australia
Human Vaccines & Immunotherapeutics
covid-19 vaccines
drug-related side effects and adverse reactions
herpes zoster
pharmacovigilance
taste disorders
title Oral adverse events following COVID-19 and influenza vaccination in Australia
title_full Oral adverse events following COVID-19 and influenza vaccination in Australia
title_fullStr Oral adverse events following COVID-19 and influenza vaccination in Australia
title_full_unstemmed Oral adverse events following COVID-19 and influenza vaccination in Australia
title_short Oral adverse events following COVID-19 and influenza vaccination in Australia
title_sort oral adverse events following covid 19 and influenza vaccination in australia
topic covid-19 vaccines
drug-related side effects and adverse reactions
herpes zoster
pharmacovigilance
taste disorders
url http://dx.doi.org/10.1080/21645515.2023.2253589
work_keys_str_mv AT abanoubriad oraladverseeventsfollowingcovid19andinfluenzavaccinationinaustralia
AT julienissa oraladverseeventsfollowingcovid19andinfluenzavaccinationinaustralia
AT samehattia oraladverseeventsfollowingcovid19andinfluenzavaccinationinaustralia
AT ladislavdusek oraladverseeventsfollowingcovid19andinfluenzavaccinationinaustralia
AT miloslavklugar oraladverseeventsfollowingcovid19andinfluenzavaccinationinaustralia